We identified the human herpesvirus 6 (HHV-6)-dominant immunoglobulin M (Ig
M)-reactive virion protein as being the same 101-kDa protein (101K) previou
sly identified as the major IgG immunoreactive protein and a specific serol
ogic marker of HHV-6 infection. An immunoblot assay (IB) to detect HHV-6-sp
ecific IgM antibodies against the 101K protein in human serum samples was d
eveloped. The assay was validated by using acute- and convalescent-phase se
rum collected from children under 2 years of age in which we previously det
ected IgG seroconversion to the HHV-6 101K protein. Of 32 serum pairs which
previously demonstrated IgG seroconversion to the 101K protein, 29 had IgM
reactivity to the same protein in the acute-phase sample and the remaining
3 had reactivity in the convalescent-phase sample. We also detected HHV-6
IgM activity in sera collected from individuals greater than or equal to 4
years of age who were also IgM seropositive to measles or rubella. Results
of cross-adsorption studies using measles virus-, rubella virus-, and HHV-6
-infected cells as the adsorbing antigen indicated no cross-reactivity betw
een measles or rubella IgM and HHV-6 IgM in human serum samples. The IgM IB
detected HHV-6-specific IgM antibody to the 101K protein in 78% (63 of 81)
of tested acute-phase serum collected from young children with an undiffer
entiated rash illness by using a single serum dilution.